Quantcast

Biotech Stocks With Major Catalysts in April

You better have all your spring-cleaning out of the way to make room for a slate of clinical trial readouts and FDA decisions coming up soon. Before April’s finished, all of these biopharmaceutical stocks could swoon or soar depending on how upcoming events play out. Company (Stock Symbol) Market Capitalization Key Asset GW Pharmaceuticals (NASDAQ:GWPH) $5.1 […]

Continue Reading ...
  • 3 High-Growth Stocks That Could Soar

    Aggressive growth stocks can produce market-beating returns by disrupting industries and taking advantage of big, new trends, but there are risks. High-growth companies often spend more money than they make to stay ahead of competitors, and that means there’s little money left over to reward investors with earnings, share repurchases, or dividends. That situation can […]

    Continue Reading ...
  • 3 Stocks I’d Avoid at All Costs

    The market’s been rallying this year, and that means that most good and even many bad stocks are moving higher. It may be tempting to buy even the ugly companies out there, but resist the urge. You’re better than that. Conn’s (NASDAQ:CONN), Gogo (NASDAQ:GOGO), and HEXO (NYSEMKT:HEXO) are three investments that I would avoid at all costs here. Let’s go over why […]

    Continue Reading ...
  • This niche industry is crushing the market

    I guarantee you’ve witnessed — and probably been a part of — this industry in action within the last week, and probably within the last few hours. It’s everywhere, it’s growing, and over the past five years, it’s absolutely destroyed the market’s returns. It’s trash. We’re making more trash than ever, and the three largest […]

    Continue Reading ...
  • 3 Growth Stocks for In-the-Know Investors

    Most investors can name a long list of stocks that made early shareholders wildly rich — you know, the Apple– and Netflix-type stocks. It’s incredibly tough to spot future winners, but three Motley Fool contributors think CarGurus (NASDAQ:CARG), JD.com (NASDAQ:JD), and Charles Schwab (NYSE:SCHW) deserve investors’ attention.   Driving portfolio gains Daniel Miller (CarGurus): If you’re looking for a growth stock that many investors haven’t heard of, […]

    Continue Reading ...
  • 3 Top Tech Stocks to Buy in March

    Buying and holding technology stocks is a fantastic way for any investor to predictably beat the market over the long term. But in today’s fast-changing world, it’s not always easy to find high-quality tech names worthy of a spot in your portfolio. So we asked three top Motley Fool contributors to each find a tech […]

    Continue Reading ...
  • Lyft’s IPO: the 1 Article You Need to Read

    Shares of Lyft are expected to start trading on the Nasdaq on Friday in a highly anticipated initial public offering (IPO). Though not as large as its rival Uber, the ride-sharing company is targeting a lofty valuation of $24.3 billion (based on a $72 per-share price for its IPO). Amid the bluster and excitement, investors need to ask […]

    Continue Reading ...
  • 3 Stocks That Are Absurdly Cheap Right Now

    The stock market has been rallying so far this year. After a forgettable 2018, which ended with a sharp double-digit decline, the S&P 500 has increased 12% since the start of 2019. Nevertheless, many stocks remain well off all-time highs and are sporting cheap valuations. Gun-shy because of last year’s ugly showing, many investors are still playing […]

    Continue Reading ...
  • 2 High-Growth Stocks I’d Buy Right Now

    With the economy showing signs of cooling off, investors will have to tread carefully when it comes to buying growth stocks. That said, there are still a handful of names worth buying, even in this uncertain economic climate. The rare-disease drugmaker Catalyst Pharmaceuticals (Nasdaq: CPRX) and the Canadian pot grower HEXO (NYSEMKT: HEXO) are perfect examples. These two names […]

    Continue Reading ...
  • 3 reasons REITs should be in your portfolio

    Real estate investment trusts (REITs) have been overshadowed by the U.S. stock market until this year, and for good reason. Looking back, the S&P 500 is up 14.64% over the past three years, versus a 7.09% growth in Morningstar’s REIT category. So far this year though, REITs are off to a sizzling start — the Vanguard […]

    Continue Reading ...